Nirvana Life Sciences Inc. (CSE:NIRV)
Canada · Delayed Price · Currency is CAD 0.0700
-0.0050 (-6.67%)
Jan 20, 2026, 9:04 AM EST
Nirvana Life Sciences Market Cap
Nirvana Life Sciences has a market cap or net worth of CAD 1.6 million as of January 20, 2026. Its market cap has decreased by -84.28% in one year.
Market Cap
1.60M
Enterprise Value
1.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since March 17, 2022, Nirvana Life Sciences's market cap has decreased from 4.27M to 1.60M, a decrease of -62.41%. That is a compound annual growth rate of -22.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 1.60M | -6.67% |
| Dec 29, 2025 | 1.72M | -28.71% |
| Dec 27, 2024 | 2.41M | 150.00% |
| Dec 28, 2023 | 964.66K | -81.10% |
| Dec 19, 2022 | 5.10M | 19.58% |
| Mar 17, 2022 | 4.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.85B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.20B |
| Sienna Senior Living | 2.15B |
| Extendicare | 2.13B |
| Trulieve Cannabis | 2.02B |
| Cronos Group | 1.35B |
| Bright Minds Biosciences | 1.20B |